DOH Central Visayas chief pathologist to lead Cebu City Medical Center | Inquirer News

DOH Central Visayas chief pathologist to lead Cebu City Medical Center

By: - Reporter / @nestleCDN
/ 08:54 PM June 22, 2022

CEBU CITY — The chief pathologist of the Department of Health (DOH) in Central Visayas will assume office as chief of the Cebu City Medical Center (CCMC).

Cebu City Mayor Michael Rama on Wednesday, June 22, announced his decision to let Dr. Mary Jane Loreche handle the affairs of the CCMC.

Loreche, in an interview, said she accepted the offer of Rama to lead the CCMC, which the mayor envisioned to be like hospitals in Singapore that provide the best services to patients.

Article continues after this advertisement

“I share in his (Rama’s) vision. I believe that the least fortunate of this place should be given the best medical services. We have seen that during the pandemic so we need to strengthen our healthcare system,” Loreche said.

FEATURED STORIES

Asked if she will continue her functions with the DOH, Loreche said another official may replace her.

Loreche stressed that there is no bad blood between her and DOH.

Article continues after this advertisement

“Yes, no problem at all (relationship with DOH). I believe I have given my best also during the pandemic with the Department of Health,” Loreche said.

READ: Metro Cebu eyes herd immunity by October

je/abc
Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our daily newsletter

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

TAGS:

No tags found for this post.
Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our newsletter!

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

© Copyright 1997-2024 INQUIRER.net | All Rights Reserved

This is an information message

We use cookies to enhance your experience. By continuing, you agree to our use of cookies. Learn more here.